The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multi-task machine learning of the electronic medical record to predict future symptoms among patients with cancer.
 
Baijiang Yuan
No Relationships to Disclose
 
Muammar Kabir
No Relationships to Disclose
 
Kevin He
No Relationships to Disclose
 
Benjamin Grant
No Relationships to Disclose
 
Sharon Narine
No Relationships to Disclose
 
Rami Ajaj
No Relationships to Disclose
 
Luna Jia Zhan
No Relationships to Disclose
 
Aly Fawzy
No Relationships to Disclose
 
Janine Xu
No Relationships to Disclose
 
Yuhua Zhang
No Relationships to Disclose
 
Vivien Yu
No Relationships to Disclose
 
Conor French
No Relationships to Disclose
 
Wei Xu
No Relationships to Disclose
 
Rahul G. Krishnan
Honoraria - Takeda
Consulting or Advisory Role - Iterative Scopes
 
Steven Gallinger
No Relationships to Disclose
 
Monika K. Krzyzanowska
Consulting or Advisory Role - Bayer; Eisai; Ipsen; Lilly
Research Funding - Eisai (Inst); Exelixis (Inst); Lilly (Inst)
 
Tran Truong
No Relationships to Disclose
 
Geoffrey Liu
Honoraria - Abbvie; Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Jazz Pharmaceuticals; Merck; novartis; pfizer; Roche Canada; Takeda
Consulting or Advisory Role - AstraZeneca/MedImmune; novartis; pfizer; Roche Canada; takeda
Speakers' Bureau - AstraZeneca; Pfizer; Takeda
Research Funding - AstraZeneca/MedImmune (Inst); Boehringer Ingelheim; roche (Inst); Takeda
 
Robert C Grant
Consulting or Advisory Role - AstraZeneca; Eisai; Guardant Health; Ipsen; Knight Therapeutics; Pfizer